People

Insmed Incorporated has announced that its Chairman of the Board Donald Hayden, Jr is stepping down as chairman and will be replaced by Insmed President and CEO Will Lewis. Hayden, who served as chairman for 13 years, will continue as a director. Former AstraZeneca CEO David Brennan has been elected as lead independent director. In addition, former Johnson & … [Read more...] about Insmed CEO Will Lewis becomes chairman of the board as Donald Hayden, Jr steps down

Intranasal drug developer Impel NeuroPharma has announced the appointment of former Allergan VP of External Science & Innovation Ellen A. Lubman as Chief Business Officer. Her previous experience also includes stints at Kadmon Pharmaceuticals and Bristol-Myers Squibb. According to the company, Lubman will head up partnering and acquisition activities. In August … [Read more...] about Impel NeuroPharma appoints Ellen A. Lubman as Chief Business Officer

Belgian soft mist inhaler company Softhale has announced the appointment of Nevan Charles Elam to its board of directors. Currently Chairman and CEO of Rezolute, Elam was formerly Senior VP and Head of the Pulmonary Business Unit at Nektar Therapeutics. He has served on the boards of Nektar spin-out Pearl Therapeutics and Aerogen, and currently serves on the board of … [Read more...] about Nevan Charles Elam joins board of Softhale

Cambridge Design Partnership (CDP) has announced the appointment of OINDP device designer David Harris to head up the company's respiratory drug delivery development business. According to CDP, the company is entering "a new phase of growth in the sector." Harris was previously Head of Respiratory Drug Delivery at PA Consulting and at Team Consulting and also … [Read more...] about David Harris joins Cambridge Design Partnership

Dance Biopharm has announced the appointment of Phillips-Medisize President and CEO Matt Jennings to its board of directors. Phillips-Medisize is developing a connected version of Dance’s insulin soft mist inhaler device. Jennings joined Phillips-Medisize as Chairman, CEO and President in 2011; his prior experience includes 5 years as President of Teleflex and 2 … [Read more...] about Phillips-Medisize CEO Matt Jennings appointed to Dance Biopharm board of directors

Inhaled insulin developer Dance Biopharm has announced the appointment of former Novoclem Pharmaceuticals President and CEO Anne Whitaker as a Director and CEO as of October 1st, 2018. In addition to founding and heading up inhaled drug developer Novoclem, Whitaker has also held executive positions at Bausch Health, Synta Pharmaceuticals, Sanofi, and GSK. Earlier … [Read more...] about Dance Biopharm appoints Anne Whitaker as CEO

Acorda Therapeutics has announced that Chief Technology Officer Rick Batycky is leaving the company as of August 20, 2018 to head up a new private biotech firm. Batycky co-founded Civitas Therapeutics, which was acquired by Acorda in 2014, along with its CVT-301 levodopa DPI, (now known as Inbrija) and the ARCUS dry powder inhalation platform. The company filed … [Read more...] about Rick Batycky to leave Acorda ahead of FDA decision on Inbrija